William G. Kaelin, Jr., MD, is the 2019 Nobel Prize recipient in medicine or physiology. He was a medical oncology clinical fellow at the Dana-Farber Cancer Institute (DFCI), and a postdoctoral fellow in the laboratory of Dr. David Livingston, where he began his studies of tumor suppressor proteins. He became an independent investigator at the DFCI in 1992, and a Howard Hughes Medical Institute Investigator and Professor of Medicine at Harvard Medical School in 2002. The 2019 Nobel was awarded jointly to Kaelin, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.
Dr. Kaelin received his MD from Duke University and was a house officer and chief resident in internal medicine at Johns Hopkins Hospital.
This person is not in the org chart
This person is not in any offices
Casdin Capital
1 followers
Casdin Capital, LLC (“Casdin”) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.